Share price, page-84

First 84 Last

Share
Profile

Follow
eshmun

12,260 Posts.

3833

02/01/19

13:21

Post #: 37002833
Share

Originally posted by CoYs ↑

Yes, but the World's Central Banks can only control the Short Term Cash Rates. The Long Term Interest Rates which impact upon Mortgage Rates are impacted by the Bond Markets and the Central Banks have no control over Long Term Interest Rates.

Long Term Interest Rates need to normalise as Pension Funds around the World will collapse otherwise and Savers need to be rewarded. That is how the Capitalist System should work. Capital formation is the key to Investment. Having Short Term rates at 5,000 year lows for an extended period has only encouraged speculation. I agree, QE has been an absolute disaster !!

Long Term Rates are on the way up and could easily increase very quickly over the next year or two. When that happens Governments are in Big Trouble, along with the over indebted Residential Property Market, and as Government Deficits explode with interest payments on Sovereign Debt taking more and more of the tax receipts meant for basic Services, taxes will need to rise to compensate, further crimping the Economy and the spending power of Tax Payers.

Then, once the population at large loses confidence in Government (who over promise and under deliver), that is when Gold, Silver and other Precious Commodities will "hit the roof" and that is when the DCNs of this World will "hit the roof" even more............

Hang in there DCN Investors as we are on a WINNER !! (along with many, many other quality Gold Producers)

COYS

Expand

@CoYs

Great commentary. Spot on IMO.Esh

DCN Price at posting: $2.54 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

GDC

Global Data Centres not clear on future operations after AirTrunk sale payout

YAL

Yancoal makes it into the ASX200 in latest S&P rebalance

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

CNB

Carnaby Resources hits copper at Mohawk, QLD

CBL

Control Bionics expands into UK and Irish markets with NeuroNode device